SHL Telemedicine and Mayo Clinic enter agreement for use of SmartHeart™ technology across different platforms Montag, 30. August 2021 - 07:09

SmartHeart™ is already being used at Mayo Clinic and will now be implemented for broader use

Tel Aviv / Zurich, 30 August 2021 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), today announced that it has entered into an Agreement with Mayo Clinic, according to which Mayo Clinic will purchase SHL’s SmartHeartTM 12 Lead ECG unit and technology for the delivery of ECGs and related services, where Mayo Clinic will implement the SmartHeartTM for use in its clinical and patient care protocols.

“We are very pleased to be able and expand our collaboration with Mayo Clinic to additional use cases of our unique FDA-approved and patented SmartHeart™ technology for performing full 12 Lead ECG,” said Erez Nachtomy, CEO of SHL Telemedicine